Astec LifeSciences バランスシートの健全性
財務の健全性 基準チェック /16
Astec LifeSciencesの総株主資本は₹2.9B 、総負債は₹5.0Bで、負債比率は171.5%となります。総資産と総負債はそれぞれ₹8.8Bと₹5.9Bです。
主要情報
171.5%
負債資本比率
₹5.00b
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | ₹20.68m |
| エクイティ | ₹2.92b |
| 負債合計 | ₹5.90b |
| 総資産 | ₹8.82b |
財務の健全性に関する最新情報
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Recent updates
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07財務状況分析
短期負債: ASTECの 短期資産 ( ₹3.0B ) は 短期負債 ( ₹3.7B ) をカバーしていません。
長期負債: ASTECの短期資産 ( ₹3.0B ) が 長期負債 ( ₹2.2B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ASTECの 純負債対資本比率 ( 170.8% ) は 高い と見なされます。
負債の削減: ASTECの負債対資本比率は、過去 5 年間で102.5%から171.5%に増加しました。
債務返済能力: ASTECの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 2.4% )。
インタレストカバレッジ: ASTECの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。